Abstract:OBJECTIVE:To investigate the effects of survivin antisense oligodeoxynucleoties (ASODN) transfection mediated by cytofectin on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells in vitro. METHODS:A549/CDDP cells were cultured routinely in RPMI-1640 medium. Survivin ASODN mediated by cytofectin was transfected into the A549/CDDP cells. Reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry SABC assays were performed to determine the regulation of survivin expression by ASODN. The influence of ASODN transfection on apoptosis was determined by fluoroscence microscopy and Hoechst staining, agarose gel electrophoresis, flow cytometry and caspase-3 colorimetric assay. MTT assay was performed to detect the cell viability, half-maximum inhibitory concentration (IC50) and cisplatin resistance index (RI) were thereby calculated. RESULTS:Transfected by survivin ASODN for 48 h, down-regulation of survivin expression was measured, of which mRNA and protein expression was significantly down-regulated to 41.56% and 0.864 +/- 0.045, respectively (P < 0.05). Transfection with survivin ASODN caused typical apoptotic changes, including characteristic chromatin condensation, nuclear shrinkage, nuclear cleavage and the cells grew more regularly, and some cells were floating. Typical DNA ladder pattern was observed by agarose gel electrophoresis. Furthermore, apoptotic index and caspase-3 activity was enhanced to 34.03% and 1.1298 +/- 0.2502, respectively (P < 0.05). It was significantly different as compared with the control group. While combination with ASODN and 10 micromol/L cisplatin caused far more distinctive apoptotic alterations, of which AI and caspase-3 activity reached to 65.85% and 1.6805 +/- 0.2758, respectively (P < 0.05), and even compared with the single ASODN group, the difference was still significant (P < 0.05). Transfected with survivin ASODN only or with combination of cisplatin for 48 h, the inhibitory rate of cell growth was enhanced to 59.3% and 83.7% (P < 0.05), respectively, while inversely, the cell viability reduced to a lowest value. The half-maximum inhibitory concentration of cisplatin was reduced from 225.03 +/- 10.59 micromol/L to 158.84 +/- 4.26 micromol/L, and the resistant index was conversely reduced from 11.9 to 8.39. Non-sense oligodeoxynucleotides (NSODN) and liposome had no effect on the cells growth (P > 0.05). CONCLUSION:Transfection with survivin ASODN can to a great extent reverse the cisplatin resistance in human cisplatin resistant lung adenocarcinoma cells A549/CDDP in vitro, and can thereby significantly inhibit the growth of the cells. The mechanism of reversal of resistance to cisplatin by this transfection can be associated with specific down-regulation of survivin expression, which decreases the threshold of apoptosis, induces more pronounced apoptosis,and reverses the resistance to apoptosis induced by cisplatin in A549/CDDP cells in vitro.

[Relationship Between Survivin Expression and Chemosensitivity of Human Lung Cancer Cells].

Influence of SiRNA Targeting Survivin on Chemosensitivity of H460/cDDP Lung Cancer Cells

Effects of Survivin Mrna Expression on Apoptosis and Proliferation and MDR-1 in Hepatocellular Carcinoma

[Effect of Down-Regulation of Survivin Gene on Apoptosis and Cisplatin Resistance in Cisplatin Resistant Human Lung Adenocarcinoma A549/CDDP Cells].

Enhancement of Cisplatin Sensitivity in Lung Cancer Xenografts by Liposome-Mediated Delivery of the Plasmid Expressing Small Hairpin RNA Targeting Survivin.

Silencing survivin expression by siRNA in lung cancer cell enhanced apoptosis and reversed cispla tin resistance

[Silencing of Survivin Gene Enhances Chemosensitivity of Human Tongue Cancer Cell Line Tca8113 to Cisplatin].

Antisense Oligodeoxynucleotides Targeting Survivin Gene Reverse Apoptotic Resistance Induced by Cisplatin in Human Lung Adenocarcinoma Cells

[Experimental Study of Antisense Oligodeoxynucleotide Targeting Survivin Gene for Cisplatin Resistant Human Lung Adeno-Carcinoma Xenograft in Nude Mice].

Survivin of Antisense Oligodeoxynucleotides Reverse Apoptotic Resistance Induced by Cisplatin in Lung Cells

The Chemotherapy Sensitivity and Gene Expression in Lung Cancer Cell Lines

[Sensitivity of Two Cell Lines with Acquired Resistance to Gefitinib to Several Chemotherapeutic Drugs].

Down-Regulation of Lung Resistance Related Protein by Rna Interference Targeting Survivin Induces the Reversal of Chemoresistances in Hepatocellular Carcinoma

Effect and Mechanism of Survivin on Hypoxia-Induced Multidrug Resistance of Human Laryngeal Carcinoma Cells

Survivin As a Factor of Radioresistance to High-Let Carbon Ions in Human Hepatoma SMMC.7721 Cells

Influence of survivin gene RNA interference on the sensitivity to paclitaxel in breast carcinoma cell Line MCF-7

[Influence of Human Epithelial Ovarian Cancer HO-8910 Cells with Modified Survivin Gene on the Cell Cycle Distribution and Chemosensitivity].

Combination of Survivin Sirna with Neoadjuvant Chemotherapy Enhances Apoptosis and Reverses Drug Resistance in Breast Cancer Mcf-7 Cells

A Study of the Expressions of Survivin and Bcl-2 in Lung Squamous Cell Carcinoma with Different Radiosensitivity

Up‐regulation of Survivin by AKT and Hypoxia‐inducible Factor 1α Contributes to Cisplatin Resistance in Gastric Cancer

Enhancement of cisplatin sensitivity in Lewis Lung carcinoma by liposome-mediated delivery of a survivin mutant